Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis - Appiah-Kusi, E.; Petros, N.; Wilson, R.; Colizzi, M.; Bossong, M. G.; Valmaggia, L.; Mondelli, V.; McGuire, P.; Bhattacharyya, S. (Psychopharmacology, 2020)
Keywords: Adolescent; Adult; Anti-Anxiety Agents - administration & dosage; Antianxiety agents; Antipsychotic Agents - administration & dosage; Antipsychotics; Anxiety; Anxiety - blood; Anxiety - drug therapy; Anxiety - psychology; Biomedical and Life Sciences; Biomedicine; Cannabidiol; Cannabidiol - administration & dosage; Cannabinoids; Corticosteroids; Double-Blind Method; Female; Hormones; Humans; Hydrocortisone - blood; Male; Neurosciences; Original Investigation; Patients; Pharmacology/Toxicology; Psychiatry; Psychosis; Psychotic Disorders - blood; Psychotic Disorders - drug therapy; Psychotic Disorders - psychology; Risk Factors; Social Behavior; Social interactions; Speech - drug effects; Speech - physiology; Stress, Psychological - blood; Stress, Psychological - drug therapy; Stress, Psychological - psychology; Treatment Outcome; Variance analysis; Young Adult; United Kingdom; Psychosis; Cannabidiol; Trier Social Stress Test; Ultra-high risk